52% of women surveyed experienced heart valve disease symptoms1
Gender and ethnic differences matter in treatment of heart valve disease
Low income patients receive less care2
Women are less likely than men to receive treatment for symptomatic severe aortic stenosis (AS)3
Different risk profiles.
Different treatment outcomes.

With your help participating in Clinical Trials, we can explore whether a treatment approach or device is safe and effective. Data show that women are getting referred later than men4, and increasing female participation is critical to improving our understanding about the effects of new treatments for women and saving lives.
We need you.
Effectiveness and safety may differ among population subgroups depending on intrinsic/extrinsic factors, including:
Race
Ethnicity
Sex
Lifestyle
Age
Genetic background
Did you know?
Racial disparities in TAVR implantation results from several factors, including socioeconomic disparities, inherent biases in healthcare provision, fewer referrals to specialists and language barriers in some minority populations.2
Patients who are women, black, or on Medicaid are less likely to be screened for progression of valvular heart disease at appropriate intervals.8
More ethnic minority participation is needed in clinical trials
With your help we can do better...
Representation across 178 cardiovascular clinical trials9

We're here for you
We are committed to providing the highest levels of customer service to help our patients improve their quality of life. For any questions, please contact the Edwards Patient Support Center.
Give us a call
Send us an email